We are live on ! Find out more
GG

Gofen & Glossberg Portfolio holdings

AUM $3.89B
1-Year Est. Return 11.97%
This Fund
S&P 500
This Quarter Est. Return
+12.39%
1 Year Est. Return
-11.97%
3 Year Est. Return
+36.4%
5 Year Est. Return
+73.95%
10 Year Est. Return
AUM
$3.65B
AUM Growth
+$399M
Cap. Flow
+$23.1M
Cap. Flow %
0.63%
Top 10 Hldgs %
29.99%
Holding
549
New
63
Increased
188
Reduced
161
Closed
15

Top Buys

Rank Stock Value
1
UL icon
Unilever
UL
+$21.6M
2
TAIL icon
Cambria Tail Risk ETF
TAIL
+$11.3M
3
KEYS icon
Keysight
KEYS
+$4.77M
4
APD icon
Air Products & Chemicals
APD
+$3.48M
5
FISV
Fiserv Inc
FISV
+$3.08M

Sector Composition

Rank Sector Weight
1 Technology 20.14%
2 Healthcare 15.58%
3 Financials 11.72%
4 Consumer Staples 9.52%
5 Communication Services 8.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFE icon
51
Pfizer
PFE
$142B
$17M 0.47%
461,270
-42,492
-8% -$1.56M
C icon
52
Citigroup
C
$222B
$16.7M 0.46%
270,373
-885
-0.3% -$45K
DD icon
53
DuPont de Nemours
DD
$18.7B
$16.5M 0.45%
185,175
+19,985
+12% +$1.57M
SHW icon
54
Sherwin-Williams
SHW
$83.7B
$15.6M 0.43%
63,609
+9
+0% +$2.13K
VWO icon
55
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$15.6M 0.43%
310,447
-8,470
-3% -$398K
GILD icon
56
Gilead Sciences
GILD
$163B
$15.5M 0.42%
265,709
-2,972
-1% -$179K
XOM icon
57
ExxonMobil
XOM
$651B
$15.4M 0.42%
374,489
-93,970
-20% -$3.52M
IWR icon
58
iShares Russell Mid-Cap ETF
IWR
$56.1B
$15.2M 0.42%
221,627
-1,346
-0.6% -$85.7K
IJR icon
59
iShares Core S&P Small-Cap ETF
IJR
$110B
$15M 0.41%
163,139
+956
+0.6% +$78.5K
UNP icon
60
Union Pacific
UNP
$172B
$14.5M 0.4%
69,536
-866
-1% -$173K
NTRS icon
61
Northern Trust
NTRS
$22.4B
$13.9M 0.38%
149,571
-3,141
-2% -$277K
SIVB
62
DELISTED
SVB Financial Group
SIVB
$13.8M 0.38%
35,601
-6
-0% -$1.94K
NOW icon
63
ServiceNow
NOW
$114B
$13.2M 0.36%
120,225
+265
+0.2% +$27.6K
IJH icon
64
iShares Core S&P Mid-Cap ETF
IJH
$122B
$13.1M 0.36%
285,780
+8,530
+3% +$359K
ACN icon
65
Accenture
ACN
$99.9B
$12.9M 0.35%
49,435
-64
-0.1% -$15.3K
IBM icon
66
IBM
IBM
$209B
$12.7M 0.35%
105,691
-7,483
-7% -$865K
BDX icon
67
Becton Dickinson
BDX
$45.6B
$12.6M 0.35%
51,626
+1,690
+3% +$394K
SCHW
68
Charles Schwab
SCHW
$181B
$12.4M 0.34%
234,600
-12,733
-5% -$576K
EFA icon
69
iShares MSCI EAFE ETF
EFA
$78.5B
$12.3M 0.34%
168,130
-7,399
-4% -$506K
TAIL icon
70
Cambria Tail Risk ETF
TAIL
$148M
$12.3M 0.34%
595,415
+538,615
+948% +$11.3M
ROBO icon
71
ROBO Global Robotics & Automation Index ETF
ROBO
$1.94B
$12.1M 0.33%
199,380
+800
+0.4% +$43.3K
CL icon
72
Colgate-Palmolive
CL
$73.3B
$11.9M 0.33%
139,203
-1,400
-1% -$116K
ATVI
73
DELISTED
Activision Blizzard
ATVI
$11.8M 0.32%
126,837
+5,370
+4% +$436K
CSCO icon
74
Cisco
CSCO
$448B
$11.6M 0.32%
258,740
-29,926
-10% -$1.23M
EEM icon
75
iShares MSCI Emerging Markets ETF
EEM
$28.6B
$11.3M 0.31%
219,307
-2,462
-1% -$118K

Similar funds

Gofen & Glossberg's Q4 2020 Portfolio in Review

As of Q4 2020, Gofen & Glossberg held 549 positions worth $3.65B, up 12% from $3.25B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Gofen & Glossberg's Q4 2020 filing shows 63 new, 188 increased, 161 reduced and 15 closed positions. Its largest new stake was Constellation Brands: 12,448 shares worth $2.73M. The largest sale was Unilever NV New York Registry Shares, an estimated $21.5M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.

  • Gofen & Glossberg's largest Q4 2020 buy was Constellation Brands: 12,448 shares worth $2.73M.
  • Gofen & Glossberg added most to Unilever in Q4 2020, an estimated $21.6M increase.
  • Gofen & Glossberg's biggest Q4 2020 reduction was ExxonMobil, cutting an estimated $3.52M.
  • Gofen & Glossberg fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $21.5M.
  • Gofen & Glossberg's ten largest holdings make up 30% of its $3.65B portfolio in Q4 2020.
  • Gofen & Glossberg opened 63 new positions and closed 15 in Q4 2020.
  • Gofen & Glossberg's portfolio value rose 12% quarter-over-quarter to $3.65B.

Based on Gofen & Glossberg's 13F filing for Q4 2020, filed 15 Jan 2021.